NLS Pharmaceutics Ltd.
13F holders, Q1 2024 (March 31)8holders
2famous investors
$0.18avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding NLS Pharmaceutics Ltd. in their 13F filings. The largest holders were BVF Inc. ($1.0M), Armistice Capital, LLC ($391K) and Renaissance Technologies ($32K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- NLS Pharmaceutics Ltd.
- CUSIP
- H57830103
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $399K |
| Exits | 1 | $33K |
Ownership 8 holders
| BVF Inc. | 0.03% | No change | 5,747,126 | $1.0M |
| Armistice Capital, LLC | 0.01% | New | 2,172,000 | $391K |
| Renaissance Technologies | 0.00% | Add +1316.6% | 179,577 | $32K |
| XTX Topco Ltd | 0.00% | New | 25,594 | $5K |
| Citadel Advisors | 0.00% | New | 19,183 | $3K |
| Geode Capital Management, LLC | 0.00% | No change | 14,362 | $3K |
| Bank of America Corp. | 0.00% | No change | 90 | $16 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is NLS PHARMACEUTICS LTD's weight in each manager's 13F, not the share of NLS Pharmaceutics Ltd. the manager owns.